Annotation Detail

Information
Associated Genes
EGFR
Associated Variants
EGFR p.Gly719Ser (p.G719S) ( ENST00000275493.7, ENST00000455089.5, ENST00000450046.2 )
EGFR p.Gly719Arg (p.G719R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 )
EGFR p.Gly719Cys (p.G719C) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 )
EGFR p.Gly719Ser (p.G719S) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 )
EGFR p.Gly719Arg (p.G719R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 )
EGFR p.Gly719Cys (p.G719C) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 )
Associated Disease
colon carcinoma
Source Database
DisGeNET
Description
Through biochemical and cellular pharmacologic studies, we have determined that cells harboring the colon cancer-derived G719S and G724S mutants are responsive to cetuximab therapy in vitro and found that the requirement for asymmetric dimerization of these mutant EGFR to promote cellular transformation may explain their greater inhibition by cetuximab than small-molecule kinase inhibitors.
Pubmed
24894453
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.0252440941034682
Year of publication
2014
Drugs